Shanghai Junshi Biosciences Co., Ltd. (688180.SS)
CNY 29.96
(-1.77%)
CNY 29.96
(-1.77%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 698.62 Million CNY | -24.65% |
| 2022 | 927.21 Million CNY | -66.49% |
| 2021 | 2.76 Billion CNY | 126.34% |
| 2020 | 1.22 Billion CNY | 78.6% |
| 2019 | 684.4 Million CNY | 102509.45% |
| 2018 | 667 Thousand CNY | -4.99% |
| 2017 | 702 Thousand CNY | -74.67% |
| 2016 | 2.77 Million CNY | 0.61% |
| 2015 | 2.75 Million CNY | 30.32% |
| 2014 | 2.11 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 364.7 Million CNY | 20.55% |
| 2024 Q2 | 302.54 Million CNY | 13.28% |
| 2024 Q1 | 267.06 Million CNY | 9.22% |
| 2023 Q1 | 105.59 Million CNY | -91.99% |
| 2023 FY | 698.62 Million CNY | -24.65% |
| 2023 Q4 | 244.53 Million CNY | 132.41% |
| 2023 Q3 | -754.39 Million CNY | -513.94% |
| 2023 Q2 | 182.24 Million CNY | 72.58% |
| 2022 FY | 927.21 Million CNY | -66.49% |
| 2022 Q4 | 1.31 Billion CNY | 217.31% |
| 2022 Q3 | -1.12 Billion CNY | -1076.71% |
| 2022 Q1 | 402.89 Million CNY | -46.9% |
| 2022 Q2 | 115.1 Million CNY | -71.43% |
| 2021 FY | 2.76 Billion CNY | 126.34% |
| 2021 Q1 | 1.28 Billion CNY | 210.1% |
| 2021 Q2 | 269.18 Million CNY | -79.13% |
| 2021 Q3 | 264.82 Million CNY | -1.62% |
| 2021 Q4 | 758.68 Million CNY | 186.49% |
| 2020 Q1 | 153.84 Million CNY | -30.08% |
| 2020 Q3 | 319.34 Million CNY | -2.94% |
| 2020 FY | 1.22 Billion CNY | 78.6% |
| 2020 Q2 | 329.02 Million CNY | 113.87% |
| 2020 Q4 | 415.92 Million CNY | 30.24% |
| 2019 Q4 | 220.04 Million CNY | 12.47% |
| 2019 Q2 | 202.38 Million CNY | 205.05% |
| 2019 Q1 | 66.34 Million CNY | 0.0% |
| 2019 FY | 684.4 Million CNY | 102509.45% |
| 2019 Q3 | 195.63 Million CNY | -3.33% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 FY | 667 Thousand CNY | -4.99% |
| 2018 Q2 | - CNY | -100.0% |
| 2018 Q1 | 227 Thousand CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 Q1 | 688.85 Thousand CNY | 123.02% |
| 2017 FY | 702 Thousand CNY | -74.67% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 100.0% |
| 2017 Q2 | -2.9 Million CNY | -522.42% |
| 2016 Q4 | 308.87 Thousand CNY | -79.48% |
| 2016 FY | 2.77 Million CNY | 0.61% |
| 2016 Q3 | 1.5 Million CNY | 5539.0% |
| 2016 Q2 | 26.68 Thousand CNY | -0.0% |
| 2016 Q1 | 26.68 Thousand CNY | -97.16% |
| 2015 Q2 | 437.7 Thousand CNY | -0.0% |
| 2015 Q3 | 939.34 Thousand CNY | 114.61% |
| 2015 FY | 2.75 Million CNY | 30.32% |
| 2015 Q1 | 437.7 Thousand CNY | -57.31% |
| 2015 Q4 | 939.34 Thousand CNY | 0.0% |
| 2014 Q2 | 31.49 Thousand CNY | 0.0% |
| 2014 Q4 | 1.02 Million CNY | 0.0% |
| 2014 FY | 2.11 Million CNY | 0.0% |
| 2014 Q3 | 1.02 Million CNY | 3155.25% |
| 2014 Q1 | 31.49 Thousand CNY | 0.0% |